… are taking medications to treat their PD. Impact on Diagnosis/Treatment of Parkinson’s Disease: We believe our … are sufficiently accurate, they can be used to detect early cases of PD and assess the effectiveness of new … Development: Next we will be work with individuals in the early stages of PD or who exhibit signs of the disease but …

… for Parkinson’s disease (PD), the current methods used to identify people suitable for clinical trials are costly, … stimulation (TMS) — to assess neurophysiological markers. Combining these techniques may help to reveal the … provide an alternative to costly and invasive tests and can be used as a stratification tool for individuals with …

… to 80 percent of people with PD and doubles the risk of PD diagnosis after 10 years. Its presence and severity worsen … features can be used to predict who will develop the PD early on and to design new treatment or prevention … of PD-associated constipation that can help unlock the early processes of PD development before the disease …

… is an involuntary muscle contraction that pulls a body part into an abnormal position. In Parkinson's, dystonia commonly … but it's more common in those who are younger at diagnosis. Dystonia can be a symptom of Parkinson's, but it … our commitment to allocate donor dollars to high-impact research. Editorial control of all Michael J. Fox …

… Pat Beckler and her daughter Celia are known for doing their research.   It’s where they started when John, Pat’s husband … And when Pat decided she wanted to actively support science into PD, you can guess what quality she looked for.    “I … Celia and her husband know this firsthand from Eddie’s diagnosis. And while Celia says they “never dreamed” of …

… Objective/Rationale:  Alpha-synuclein is an abundant brain protein, whose misfolding has been … The disease associated misfolding of alpha-synuclein encompasses more steps from monomers via soluble misfolded … distribution during disease development are largely unknown. Large libraries of synthetic RNA molecules, aptamers …